Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Testicular Neoplasms | 15 | 2024 | 795 | 2.550 |
Why?
|
Sweat Gland Neoplasms | 3 | 2024 | 115 | 2.030 |
Why?
|
Carcinoma, Renal Cell | 15 | 2023 | 3177 | 1.630 |
Why?
|
Kidney Neoplasms | 14 | 2023 | 4274 | 1.480 |
Why?
|
Skin Neoplasms | 10 | 2024 | 5726 | 1.330 |
Why?
|
Adenoma, Oxyphilic | 4 | 2020 | 147 | 1.230 |
Why?
|
Immunohistochemistry | 27 | 2024 | 11007 | 1.200 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2024 | 4004 | 1.120 |
Why?
|
Sebaceous Gland Neoplasms | 2 | 2019 | 40 | 1.090 |
Why?
|
Orchiectomy | 5 | 2022 | 470 | 1.040 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 4 | 2024 | 492 | 1.020 |
Why?
|
Granulosa Cell Tumor | 4 | 2023 | 71 | 0.970 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 5 | 2023 | 112 | 0.950 |
Why?
|
Penile Neoplasms | 2 | 2024 | 163 | 0.940 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2021 | 2252 | 0.940 |
Why?
|
RNA-Binding Proteins | 5 | 2018 | 1894 | 0.930 |
Why?
|
Neoplasm Staging | 4 | 2024 | 11064 | 0.900 |
Why?
|
Repressor Proteins | 3 | 2019 | 2973 | 0.870 |
Why?
|
Hemangiosarcoma | 2 | 2015 | 218 | 0.860 |
Why?
|
Poroma | 1 | 2022 | 10 | 0.850 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2020 | 587 | 0.850 |
Why?
|
Eccrine Porocarcinoma | 1 | 2022 | 18 | 0.840 |
Why?
|
Urine | 2 | 2021 | 363 | 0.830 |
Why?
|
Retinoblastoma Binding Proteins | 2 | 2019 | 95 | 0.810 |
Why?
|
Nevus | 1 | 2024 | 204 | 0.800 |
Why?
|
Carcinoma, Papillary | 3 | 2020 | 782 | 0.790 |
Why?
|
Hamartoma | 1 | 2023 | 232 | 0.770 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2021 | 3600 | 0.750 |
Why?
|
Adenocarcinoma | 5 | 2024 | 6306 | 0.730 |
Why?
|
Carcinoma, Basal Cell | 2 | 2019 | 555 | 0.730 |
Why?
|
Melanoma | 5 | 2024 | 5620 | 0.720 |
Why?
|
Urethral Neoplasms | 1 | 2020 | 37 | 0.710 |
Why?
|
Adenosarcoma | 1 | 2020 | 36 | 0.690 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2015 | 990 | 0.690 |
Why?
|
Tuberous Sclerosis | 3 | 2023 | 1028 | 0.690 |
Why?
|
Uterine Neoplasms | 3 | 2020 | 1444 | 0.660 |
Why?
|
Carcinoma, Skin Appendage | 1 | 2018 | 5 | 0.640 |
Why?
|
Urogenital Neoplasms | 1 | 2020 | 135 | 0.630 |
Why?
|
Sertoli Cell Tumor | 3 | 2023 | 36 | 0.620 |
Why?
|
Keratosis, Seborrheic | 1 | 2018 | 27 | 0.620 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2018 | 65 | 0.610 |
Why?
|
Adenoma, Pleomorphic | 1 | 2018 | 74 | 0.600 |
Why?
|
Adrenal Rest Tumor | 1 | 2017 | 5 | 0.600 |
Why?
|
Biopsy | 13 | 2022 | 6743 | 0.590 |
Why?
|
Carcinoma, Endometrioid | 1 | 2020 | 277 | 0.570 |
Why?
|
Histiocytes | 2 | 2018 | 98 | 0.570 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2017 | 311 | 0.550 |
Why?
|
Adrenocortical Carcinoma | 1 | 2017 | 86 | 0.550 |
Why?
|
Histiocytosis | 1 | 2016 | 40 | 0.540 |
Why?
|
Diagnosis, Differential | 16 | 2022 | 12898 | 0.540 |
Why?
|
Skin | 4 | 2019 | 4421 | 0.530 |
Why?
|
Adenoma | 3 | 2020 | 2141 | 0.530 |
Why?
|
Amyloidosis, Familial | 1 | 2015 | 16 | 0.530 |
Why?
|
Sexual Development | 1 | 2015 | 40 | 0.520 |
Why?
|
Carcinoma | 3 | 2020 | 2340 | 0.520 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2017 | 159 | 0.520 |
Why?
|
Chromosomes, Human, Pair 12 | 2 | 2023 | 431 | 0.520 |
Why?
|
Skin Diseases, Genetic | 1 | 2015 | 42 | 0.500 |
Why?
|
Endodermal Sinus Tumor | 1 | 2015 | 53 | 0.490 |
Why?
|
Eyelid Neoplasms | 1 | 2016 | 94 | 0.490 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2015 | 119 | 0.480 |
Why?
|
Prostatic Neoplasms | 9 | 2024 | 11266 | 0.480 |
Why?
|
Urinary Bladder | 1 | 2021 | 1169 | 0.470 |
Why?
|
Succinate Dehydrogenase | 1 | 2015 | 144 | 0.470 |
Why?
|
Mucins | 2 | 2022 | 568 | 0.470 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2021 | 798 | 0.460 |
Why?
|
Leydig Cell Tumor | 2 | 2024 | 28 | 0.430 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2019 | 1873 | 0.430 |
Why?
|
In Situ Hybridization, Fluorescence | 6 | 2023 | 2495 | 0.420 |
Why?
|
Hair Diseases | 1 | 2013 | 72 | 0.420 |
Why?
|
Teratoma | 1 | 2015 | 401 | 0.420 |
Why?
|
Granuloma | 2 | 2022 | 325 | 0.410 |
Why?
|
Rare Diseases | 1 | 2017 | 613 | 0.410 |
Why?
|
Lymphatic Vessels | 1 | 2016 | 354 | 0.400 |
Why?
|
Prostate | 7 | 2024 | 1784 | 0.390 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 1391 | 0.390 |
Why?
|
Keratinocytes | 1 | 2015 | 787 | 0.390 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2018 | 1085 | 0.380 |
Why?
|
Dermatitis | 1 | 2013 | 200 | 0.380 |
Why?
|
Thyroid Gland | 1 | 2017 | 1166 | 0.370 |
Why?
|
DNA Mismatch Repair | 1 | 2014 | 427 | 0.370 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 1359 | 0.360 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2015 | 732 | 0.350 |
Why?
|
Melanocytes | 1 | 2013 | 511 | 0.350 |
Why?
|
Humans | 83 | 2024 | 752341 | 0.350 |
Why?
|
Predictive Value of Tests | 11 | 2024 | 15130 | 0.350 |
Why?
|
Male | 55 | 2024 | 354881 | 0.340 |
Why?
|
Aged | 33 | 2024 | 166562 | 0.330 |
Why?
|
Skin Diseases | 1 | 2018 | 1083 | 0.330 |
Why?
|
Chromosome Aberrations | 1 | 2015 | 1767 | 0.330 |
Why?
|
ras Proteins | 1 | 2014 | 1046 | 0.320 |
Why?
|
Co-Repressor Proteins | 2 | 2019 | 189 | 0.300 |
Why?
|
Leiomyosarcoma | 1 | 2012 | 426 | 0.300 |
Why?
|
Lymphatic Metastasis | 4 | 2024 | 2924 | 0.290 |
Why?
|
Thyroid Neoplasms | 2 | 2017 | 2309 | 0.280 |
Why?
|
Mutation | 10 | 2024 | 29705 | 0.270 |
Why?
|
Prognosis | 7 | 2021 | 29327 | 0.270 |
Why?
|
Middle Aged | 31 | 2024 | 217019 | 0.270 |
Why?
|
Necrosis | 3 | 2015 | 1600 | 0.260 |
Why?
|
Seminoma | 2 | 2023 | 133 | 0.260 |
Why?
|
Central Nervous System Neoplasms | 1 | 2013 | 905 | 0.250 |
Why?
|
Fatal Outcome | 3 | 2020 | 1828 | 0.250 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2015 | 2035 | 0.250 |
Why?
|
Leukemia | 1 | 2013 | 1500 | 0.240 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2020 | 319 | 0.240 |
Why?
|
Breast Neoplasms | 4 | 2018 | 20843 | 0.240 |
Why?
|
DNA Mutational Analysis | 3 | 2020 | 4110 | 0.240 |
Why?
|
Tumor Burden | 5 | 2018 | 1875 | 0.230 |
Why?
|
Birt-Hogg-Dube Syndrome | 1 | 2023 | 38 | 0.220 |
Why?
|
Carney Complex | 1 | 2023 | 15 | 0.220 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2899 | 0.220 |
Why?
|
Soft Tissue Neoplasms | 1 | 2012 | 1149 | 0.220 |
Why?
|
Female | 32 | 2024 | 386053 | 0.220 |
Why?
|
Neoplasm Invasiveness | 4 | 2015 | 3585 | 0.220 |
Why?
|
Malacoplakia | 1 | 2022 | 14 | 0.210 |
Why?
|
Myelodysplastic Syndromes | 1 | 2013 | 1376 | 0.210 |
Why?
|
Rete Testis | 1 | 2022 | 10 | 0.210 |
Why?
|
Aged, 80 and over | 12 | 2022 | 58300 | 0.210 |
Why?
|
Eccrine Glands | 1 | 2022 | 50 | 0.210 |
Why?
|
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2022 | 24 | 0.200 |
Why?
|
Scrotum | 1 | 2022 | 115 | 0.200 |
Why?
|
Lung Neoplasms | 4 | 2016 | 13165 | 0.200 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 1686 | 0.200 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2021 | 304 | 0.200 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2024 | 720 | 0.200 |
Why?
|
beta Catenin | 2 | 2024 | 1040 | 0.200 |
Why?
|
Transurethral Resection of Prostate | 1 | 2022 | 85 | 0.200 |
Why?
|
Urothelium | 2 | 2020 | 276 | 0.190 |
Why?
|
Granular Cell Tumor | 1 | 2021 | 48 | 0.190 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4474 | 0.190 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2023 | 239 | 0.190 |
Why?
|
Salivary Glands, Minor | 1 | 2020 | 25 | 0.190 |
Why?
|
Merkel Cells | 1 | 2020 | 24 | 0.180 |
Why?
|
Hyperplasia | 2 | 2022 | 1154 | 0.180 |
Why?
|
Cutis Laxa | 1 | 2020 | 29 | 0.180 |
Why?
|
Vaginal Neoplasms | 1 | 2021 | 105 | 0.180 |
Why?
|
Cytogenetic Analysis | 1 | 2020 | 272 | 0.170 |
Why?
|
Immunocompromised Host | 3 | 2024 | 854 | 0.170 |
Why?
|
Urologic Neoplasms | 2 | 2020 | 321 | 0.170 |
Why?
|
Lasers, Gas | 1 | 2020 | 92 | 0.160 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5786 | 0.160 |
Why?
|
Foreskin | 1 | 2018 | 31 | 0.160 |
Why?
|
Sjogren's Syndrome | 1 | 2020 | 234 | 0.160 |
Why?
|
Pancytopenia | 1 | 2019 | 101 | 0.160 |
Why?
|
Cryoglobulinemia | 1 | 2019 | 84 | 0.160 |
Why?
|
Adult | 22 | 2024 | 216913 | 0.160 |
Why?
|
Kidney | 3 | 2023 | 6983 | 0.160 |
Why?
|
Epithelioid Cells | 1 | 2018 | 60 | 0.160 |
Why?
|
Syndactyly | 1 | 2018 | 70 | 0.160 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2022 | 519 | 0.150 |
Why?
|
Hormones | 1 | 2022 | 872 | 0.150 |
Why?
|
Retinal Ganglion Cells | 1 | 2024 | 795 | 0.150 |
Why?
|
Mycobacterium haemophilum | 1 | 2017 | 1 | 0.150 |
Why?
|
Sweet Syndrome | 1 | 2018 | 55 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6501 | 0.150 |
Why?
|
Testis | 1 | 2021 | 793 | 0.150 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9355 | 0.150 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2018 | 73 | 0.150 |
Why?
|
Cytomegalovirus Infections | 1 | 2024 | 826 | 0.150 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2019 | 211 | 0.150 |
Why?
|
Sarcoma, Synovial | 1 | 2018 | 150 | 0.140 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2016 | 46 | 0.140 |
Why?
|
Scapula | 1 | 2018 | 172 | 0.140 |
Why?
|
Mycobacterium Infections | 1 | 2017 | 121 | 0.140 |
Why?
|
Paraffin Embedding | 1 | 2018 | 302 | 0.140 |
Why?
|
Tissue Fixation | 1 | 2018 | 240 | 0.140 |
Why?
|
Gender Identity | 1 | 2022 | 694 | 0.140 |
Why?
|
Sarcoidosis | 1 | 2022 | 515 | 0.140 |
Why?
|
Neck Dissection | 1 | 2017 | 200 | 0.130 |
Why?
|
Formaldehyde | 1 | 2018 | 357 | 0.130 |
Why?
|
Contracture | 1 | 2018 | 233 | 0.130 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 264 | 0.130 |
Why?
|
Young Adult | 10 | 2024 | 57629 | 0.130 |
Why?
|
Neuroblastoma | 1 | 2023 | 1240 | 0.130 |
Why?
|
Nephrectomy | 1 | 2021 | 1000 | 0.130 |
Why?
|
Hemangiopericytoma | 1 | 2015 | 72 | 0.120 |
Why?
|
Cell Nucleolus | 1 | 2015 | 157 | 0.120 |
Why?
|
Peptide Hydrolases | 1 | 2018 | 620 | 0.120 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2023 | 1572 | 0.120 |
Why?
|
Time Factors | 5 | 2024 | 39854 | 0.120 |
Why?
|
Synapses | 1 | 2024 | 1747 | 0.120 |
Why?
|
Brachytherapy | 1 | 2022 | 1241 | 0.120 |
Why?
|
Opportunistic Infections | 1 | 2017 | 377 | 0.120 |
Why?
|
Mitotic Index | 1 | 2014 | 161 | 0.120 |
Why?
|
Biological Products | 1 | 2023 | 900 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2018 | 64245 | 0.110 |
Why?
|
Skin Transplantation | 1 | 2018 | 1025 | 0.110 |
Why?
|
Histones | 1 | 2023 | 2566 | 0.110 |
Why?
|
Retina | 1 | 2024 | 2624 | 0.110 |
Why?
|
Calcinosis | 1 | 2022 | 1478 | 0.110 |
Why?
|
Gene Rearrangement | 1 | 2017 | 1112 | 0.100 |
Why?
|
Biopsy, Fine-Needle | 1 | 2017 | 1108 | 0.100 |
Why?
|
Thyroidectomy | 1 | 2017 | 896 | 0.100 |
Why?
|
Child, Preschool | 6 | 2022 | 41659 | 0.100 |
Why?
|
Foot | 1 | 2015 | 566 | 0.100 |
Why?
|
Upper Extremity | 1 | 2016 | 646 | 0.090 |
Why?
|
Thoracotomy | 1 | 2013 | 360 | 0.090 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2015 | 548 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1247 | 0.090 |
Why?
|
Gene Deletion | 1 | 2018 | 2665 | 0.090 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1774 | 0.090 |
Why?
|
Prostatectomy | 3 | 2023 | 1917 | 0.090 |
Why?
|
Mitosis | 3 | 2023 | 1192 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2018 | 2904 | 0.080 |
Why?
|
Laryngeal Neoplasms | 1 | 2013 | 513 | 0.080 |
Why?
|
Infant | 5 | 2023 | 35673 | 0.080 |
Why?
|
Lymph Node Excision | 1 | 2015 | 1290 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2021 | 3285 | 0.080 |
Why?
|
Stromal Cells | 1 | 2014 | 1317 | 0.080 |
Why?
|
Mesothelioma | 2 | 2013 | 830 | 0.080 |
Why?
|
MicroRNAs | 1 | 2024 | 3764 | 0.080 |
Why?
|
Disease-Free Survival | 2 | 2015 | 6781 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2782 | 0.080 |
Why?
|
Poland | 2 | 2020 | 196 | 0.070 |
Why?
|
Carcinoma in Situ | 1 | 2013 | 794 | 0.070 |
Why?
|
Burns | 1 | 2018 | 1854 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3489 | 0.070 |
Why?
|
Epithelium | 1 | 2011 | 1606 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2015 | 1177 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3165 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4808 | 0.070 |
Why?
|
Pleural Neoplasms | 1 | 2011 | 625 | 0.070 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 21712 | 0.070 |
Why?
|
Breast | 1 | 2015 | 1975 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14586 | 0.060 |
Why?
|
Anemia | 1 | 2015 | 1495 | 0.060 |
Why?
|
Crohn Disease | 1 | 2017 | 2256 | 0.060 |
Why?
|
Peritoneal Neoplasms | 1 | 2011 | 700 | 0.060 |
Why?
|
Skin Diseases, Viral | 1 | 2024 | 26 | 0.060 |
Why?
|
Amacrine Cells | 1 | 2024 | 52 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2024 | 79127 | 0.060 |
Why?
|
Cell Proliferation | 3 | 2015 | 10358 | 0.060 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6793 | 0.060 |
Why?
|
Integrin alpha2 | 1 | 2023 | 39 | 0.060 |
Why?
|
Child | 6 | 2022 | 78998 | 0.050 |
Why?
|
Reoperation | 1 | 2013 | 4256 | 0.050 |
Why?
|
Skin Ulcer | 1 | 2024 | 129 | 0.050 |
Why?
|
Massachusetts | 1 | 2015 | 8707 | 0.050 |
Why?
|
Prostate-Specific Antigen | 2 | 2022 | 2524 | 0.050 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2018 | 3589 | 0.050 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2023 | 276 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2016 | 2868 | 0.050 |
Why?
|
Adolescent | 4 | 2024 | 86765 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2018 | 9207 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12455 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2020 | 19894 | 0.050 |
Why?
|
Motion Perception | 1 | 2024 | 370 | 0.050 |
Why?
|
Urethra | 1 | 2022 | 404 | 0.040 |
Why?
|
Visual Pathways | 1 | 2024 | 533 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2024 | 754 | 0.040 |
Why?
|
Taiwan | 1 | 2020 | 504 | 0.040 |
Why?
|
Lysine | 1 | 2023 | 990 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2024 | 35916 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18297 | 0.040 |
Why?
|
Angiomyolipoma | 1 | 2020 | 182 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 2019 | 278 | 0.040 |
Why?
|
Purpura | 1 | 2019 | 117 | 0.040 |
Why?
|
Urinalysis | 1 | 2020 | 367 | 0.040 |
Why?
|
Subcutaneous Tissue | 1 | 2018 | 131 | 0.040 |
Why?
|
Genomics | 2 | 2023 | 5727 | 0.040 |
Why?
|
Jaw | 1 | 2016 | 93 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2020 | 1091 | 0.030 |
Why?
|
Disease Progression | 1 | 2013 | 13402 | 0.030 |
Why?
|
Leukocyte Disorders | 1 | 2015 | 13 | 0.030 |
Why?
|
Gene Fusion | 1 | 2018 | 352 | 0.030 |
Why?
|
Neck | 1 | 2020 | 724 | 0.030 |
Why?
|
Indiana | 1 | 2015 | 91 | 0.030 |
Why?
|
Microscopy | 1 | 2020 | 882 | 0.030 |
Why?
|
alpha-Fetoproteins | 1 | 2015 | 220 | 0.030 |
Why?
|
Edema | 1 | 2019 | 771 | 0.030 |
Why?
|
Exanthema | 1 | 2019 | 501 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2023 | 11422 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3288 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2018 | 1056 | 0.030 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2019 | 694 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2015 | 651 | 0.030 |
Why?
|
Preoperative Period | 1 | 2015 | 549 | 0.030 |
Why?
|
Inflammation | 2 | 2023 | 10690 | 0.030 |
Why?
|
Boston | 2 | 2015 | 9236 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2064 | 0.030 |
Why?
|
Nerve Net | 1 | 2024 | 2194 | 0.030 |
Why?
|
Oncogenes | 1 | 2018 | 1215 | 0.030 |
Why?
|
Fever | 1 | 2019 | 1611 | 0.030 |
Why?
|
Fatigue | 1 | 2019 | 1522 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2015 | 1590 | 0.020 |
Why?
|
Laryngectomy | 1 | 2013 | 244 | 0.020 |
Why?
|
Peritoneum | 1 | 2011 | 221 | 0.020 |
Why?
|
DNA, Viral | 1 | 2016 | 2176 | 0.020 |
Why?
|
Pleura | 1 | 2011 | 243 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2023 | 25914 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2902 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 53807 | 0.020 |
Why?
|
Graft Survival | 1 | 2018 | 3626 | 0.020 |
Why?
|
China | 1 | 2014 | 2331 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2024 | 8422 | 0.020 |
Why?
|
Actins | 1 | 2015 | 2048 | 0.020 |
Why?
|
Lymphocytes | 1 | 2015 | 2592 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6058 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2014 | 1527 | 0.020 |
Why?
|
Mice | 2 | 2024 | 80543 | 0.020 |
Why?
|
Contrast Media | 1 | 2020 | 5276 | 0.020 |
Why?
|
Gestational Age | 1 | 2015 | 3546 | 0.020 |
Why?
|
Preoperative Care | 1 | 2015 | 2232 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4115 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2421 | 0.020 |
Why?
|
Cytokines | 1 | 2019 | 7235 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4067 | 0.020 |
Why?
|
Neutrophils | 1 | 2015 | 3724 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2017 | 4117 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10177 | 0.010 |
Why?
|
Animals | 2 | 2024 | 166802 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2018 | 9551 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12746 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16439 | 0.010 |
Why?
|
United States | 2 | 2020 | 71442 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9429 | 0.010 |
Why?
|
HIV Infections | 1 | 2024 | 17006 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21158 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17648 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 23783 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 73412 | 0.010 |
Why?
|